NK521
/ Base Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 19, 2026
NK521 in the Treatment of Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=18 | Not yet recruiting | Sponsor: Base Therapeutics (Shanghai) Co., Ltd.
New P1 trial • Hepatocellular Cancer • Oncology • Ovarian Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1